In this study we have used ATF technology to successfully suppress SCC in vitro and in vivo in SOX2-expressing SCC lung and esophageal cancer cells as a first step in the search for an effective treatment for SCC lung and esophageal cancers. Here, SOX2 is linked to esophageal cancer.